AstraZeneca vs Structure Therapeutics: Revenue Comparison
AstraZeneca (AZN) and Structure Therapeutics (GPCR) are peers in GLP-1. AstraZeneca reported revenue of $15.3B as of Q1 2026, compared with $0 for Structure Therapeutics. AstraZeneca leads on revenue.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: AstraZeneca 15.288, Structure Therapeutics 0.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, AstraZeneca, Structure Therapeutics.| Metric | AstraZeneca | Structure Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.29B | $0 |
| Cost of Revenue | $2.68B | $1.00M |
| Gross Profit | $12.61B | $-1.00M |
| Operating Income | $4.25B | $-90.00M |
| Net Income | $3.08B | $-76.00M |
| R&D Expense | $3.49B | $67.00M |
| Earnings Per Share | $3.94 | -$1.05 |
| Gross Margin | 82.5% | - |
| Operating Margin | 27.8% | - |
| Net Profit Margin | 20.1% | - |
| Free Cash Flow | $1.82B | $14.00M |
| Cumulative Free Cash Flow | $119.09B | $-469.00M |
| Operating Cash Flow | $3.36B | $15.00M |
| Cash & Equivalents | $7.56B | $316.00M |